Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998052569) COMBINATION THERAPY FOR MODULATING THE HUMAN SEXUAL RESPONSE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052569 International Application No.: PCT/US1998/010230
Publication Date: 26.11.1998 International Filing Date: 19.05.1998
Chapter 2 Demand Filed: 07.12.1998
IPC:
A61K 31/505 (2006.01) ,A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
ZONAGEN, INC. [US/US]; A Delaware Corporation 2408 Timberloch Place, B-4 The Woodlands, TX 77380, US (AllExceptUS)
PODOLSKI, Joseph, S. [US/US]; US (UsOnly)
Inventors:
PODOLSKI, Joseph, S.; US
Agent:
CLOUGH, David, W. ; Marshall, O'Toole, Gerstein, Murray & Borun 6300 Sears Tower 233 S. Wacker Drive Chicago, IL 60606-6402, US
Priority Data:
60/049,94719.05.1997US
Title (EN) COMBINATION THERAPY FOR MODULATING THE HUMAN SEXUAL RESPONSE
(FR) THERAPIE COMBINATOIRE PERMETTANT DE MODULER LA REPONSE SEXUELLE CHEZ UN PATIENT
Abstract:
(EN) The invention is directed to compositions and methods for modulating the human sexual response. The compositions comprise two or more pharmaceutically active agents which preferably include an alpha-adrenergic antagonist and a phosphodiesterase inhibitor.
(FR) Cette invention concerne des compositions et des procédés qui permettent de moduler la réponse sexuelle chez un patient. Ces compositions contiennent au moins deux agents pharmaceutiques actifs qui comprennent, de préférence, un antagoniste alpha-adrénergique ainsi qu'un inhibiteur de phosphodiestérase.
Designated States: AU, BR, CA, CN, IL, JP, KR, MX, NO, NZ, SG, US
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
NO19995657MXPA/a/1999/010400KR1020010012721SG68848BRPI9809848EP0996447
JP2009280621JP2001526686 CN1262622CA2291160NZ500921AU1998074980
DK0996447